Related references
Note: Only part of the references are listed.Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts
H Grundmann et al.
Eurosurveillance (2017)
Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
Matthew E. Falagas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Treating infections caused by carbapenemase-producing Enterobacteriaceae
L. S. Tzouvelekis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study
M. Giannella et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections
Yanina Dubrovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit
Francesco Sbrana et al.
CLINICAL INFECTIOUS DISEASES (2013)
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
A. Capone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections
Pierluigi Viale et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R. P. Dellinger et al.
INTENSIVE CARE MEDICINE (2013)
Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Elizabeth B. Hirsch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria
M. Akova et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
R. Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
Grace C. Lee et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2012)
In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a KPC Carbapenemase
Dora E. Wiskirchen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Neil Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
O. Zarkotou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
G. L. Daikos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay
Spyros Pournaras et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
Elizabeth B. Hirsch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
Azza Elemam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
Jesus Rodriguez-Bano et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
Andrea Endimiani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Drug therapy: Management of sepsis
Jarnes A. Russell
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
